GeneQuine Biotherapeutics Changes Name to GQ Bio Therapeutics, Expands Facilities and Appoints Industry Veteran to Board

Hamburg, Germany, May 9, 2023 – GeneQuine Biotherapeutics GmbH today announced that it is changing its name to GQ Bio Therapeutics GmbH. Since 2012, the company has been working under the name GeneQuine Biotherapeutics

in the field of gene therapy…

2 Min
More

Evosep and Cellenion enter co-marketing agreement to boost single cell proteomics

Lyon, France, and Odense, Denmark; May 9, 2023: Today at AOHUPO in Singapore, Cellenion is pleased to announce a new co-marketing partnership with Evosep. This partnership will enable researchers to access a complete solution for single-cell…

2 Min
More

BIOTRONIK Receives CE Approval for the World’s First Pacemaker and CRT-P Family Approved for Left Bundle Branch Pacing

The Amvia family enables physiological pacing and workflow optimization to help physicians deliver exceptional patient-centric care with less effort.

 

2 Min
More

How cancer genes become independent

Sometimes a tumor suddenly starts growing rapidly or becomes resistant to cancerdrugs. This can be caused by a cancer gene “striking out on its own” in ring shapes. ECRC-scientist Anton Henssen described how these DNA rings arise and continue to…

3 Min
More

Interview | Prof. Dr. Emmanuelle Charpentier, Max Planck Unit for the Science of Pathogens (MPUSP)

"Basic research is the basis for innovation"

1 Min
More

Targeting chronic inflammation: Prof. Dr. Eicke Latz starts at Charité and German Rheumatism Research Centre

New Professor of Experimental Rheumatology and Scientific Director of the DRFZ

The Charité – Universitätsmedizin Berlin appointed Prof. Dr. Eicke Latz as Professor of Experimental Rheumatology on 1 May. He simultaneously became the new Scientific…

3 Min
More

An international team led by Charité – Universitätsmedizin Berlin has constructed the largest cellular proteomic map to date, using yeasts as model organisms

A proteome is the entirety of all active protein molecules present within an organism, a certain type of tissue, or a cell under specific conditions and at a certain time. Now, an international team of researchers led by members from Charité –…

4 Min
More

3B Pharmaceuticals from Berlin announced licensing agreement with Novartis Innovative Therapies

 

Berlin, April 24, 2023 – 3B Pharmaceuticals GmbH (3BP), a private German biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications, today announced that it has entered into an amended and restated…

2 Min
More

Eckert & Ziegler Receives Manufacturing Authorization for GMP-grade Lutetium-177

Berlin, 20 April 2023 - Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), has received the manufacturing authorization for Lutetium-177 (non-carrier-added Lu-177) in GMP…

2 Min
More

FDA Approval for BIOTRONIK’s Prospera™ Spinal Cord Stimulation System

Global Leader in Cardiac Rhythm Technology Solutions Expands Therapies for the Treatment of Chronic Intractable Pain with a New Approach to Managing Spinal Cord Stimulation

3 Min
More
Show more items